Janney Montgomery Scott LLC Sells 5,669 Shares of Abrdn Life Sciences Investors (NYSE:HQL)

Janney Montgomery Scott LLC lessened its position in shares of Abrdn Life Sciences Investors (NYSE:HQL) by 6.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 85,198 shares of the company’s stock after selling 5,669 shares during the quarter. Janney Montgomery Scott LLC owned about 0.31% of Abrdn Life Sciences Investors worth $1,285,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the company. Future Financial Wealth Managment LLC acquired a new position in Abrdn Life Sciences Investors during the 3rd quarter valued at about $30,000. B. Riley Wealth Advisors Inc. bought a new stake in shares of Abrdn Life Sciences Investors during the first quarter worth approximately $143,000. Sanctuary Advisors LLC acquired a new position in Abrdn Life Sciences Investors in the second quarter valued at approximately $154,000. Stephens Inc. AR boosted its stake in Abrdn Life Sciences Investors by 7.6% in the third quarter. Stephens Inc. AR now owns 12,707 shares of the company’s stock valued at $192,000 after acquiring an additional 896 shares during the last quarter. Finally, International Assets Investment Management LLC acquired a new stake in Abrdn Life Sciences Investors during the 3rd quarter worth $204,000. Institutional investors own 32.21% of the company’s stock.

Abrdn Life Sciences Investors Price Performance

HQL stock opened at $14.42 on Friday. Abrdn Life Sciences Investors has a twelve month low of $11.62 and a twelve month high of $15.90. The business’s fifty day moving average is $15.03 and its 200-day moving average is $14.64.

Abrdn Life Sciences Investors Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 10th. Shareholders of record on Thursday, November 21st will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Thursday, November 21st. This represents a $2.00 dividend on an annualized basis and a yield of 13.87%. This is a boost from Abrdn Life Sciences Investors’s previous quarterly dividend of $0.49.

About Abrdn Life Sciences Investors

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.